Drugs / GI-270384
last change Dec 2004 re-read 3 minutes ago

GI-270384

Developed for
ulcerative colitis
Investigated by
GlaxoSmithKline

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00457171 Dec 2004 → ? ulcerative colitis GlaxoSmithKline Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GI-270384 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00457171 ↗